Business Context and Reporting Period
This Form 8-K is a current report filed by PerkinElmer, Inc. (Note: The request metadata lists "REVVITY, INC.", but the filing text identifies the registrant as PerkinElmer, Inc.) on April 28, 2009. The report details corporate governance actions taken on this date, specifically the shareholder approval of a new equity incentive plan and amendments to the company's By-laws.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance and compensation plan approvals.
Material Changes
- 2009 Incentive Plan Approval: Shareholders approved the 2009 Incentive Plan, authorizing the grant of up to 10,000,000 shares. This plan replaces the Amended and Restated 2001 Incentive Plan, the 2005 Incentive Plan, and the Amended and Restated Life Sciences Incentive Plan for future grants.
- By-laws Amendment: The Board of Directors approved amendments to the By-laws modifying notice requirements for shareholders seeking to nominate directors or propose business. New requirements include disclosure of security holdings (including derivatives and short positions), hedging arrangements, and nominee relationships.
Guidance, Outlook, and Management Commentary
The filing contains no financial guidance, outlook, or management commentary regarding future business performance. The text describes the mechanics of the new incentive plan, including:
- Eligibility: Employees, officers, and directors of the Company and its subsidiaries.
- Award Types: Incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock, restricted stock units, and cash awards.
- Individual Limits:
- Maximum of 800,000 shares per fiscal year for existing participants.
- Maximum of 1,500,000 shares for newly hired or promoted employees.
- Maximum of 500,000 shares for performance awards settled in common stock.
- Maximum cash payment of $15,000,000 per calendar year for performance awards (capped at $5,000,000 for annual bonuses and $10,000,000 for multi-year awards).
Investor Verification Checklist
- Verify the total number of shares authorized under the 2009 Incentive Plan (10,000,000) and the treatment of forfeited shares from prior plans.
- Review the specific terms of the amended By-laws (Exhibit 3.1) regarding shareholder nomination notice periods and disclosure requirements.
- Confirm the cessation of new grants under the 2001, 2005, and Life Sciences Incentive Plans.
- Examine the specific award agreement forms (Exhibits 10.2 through 10.8) for details on vesting schedules and performance criteria.